13F Data
13F filer · CIK 1822947

Ally Bridge Group (NY) LLC

NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$113.1M
$-10.7M vs prior
Positions
25
New / sold out
12 / 14
Added / reduced
2 / 9
Turnover
59.4%
buys $70.3M · sells $88.6M
Top-10 weight
70.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewDEFINIUM THERAPEUTICS INCCALL+400,000–+$18.8M
NewABIVAX SACALL+125,000–+$16.7M
NewFIRST TRACKS BIOTHERAPEUTICS+284,287–+$5.7M
NewAXSOME THERAPEUTICS INC+16,493–+$4.0M
NewASSEMBLY BIOSCIENCES INC+140,000–+$3.8M
NewCLIMB BIO INC+249,172–+$3.2M
NewKURA ONCOLOGY INC+290,000–+$3.2M
AddedMINERVA NEUROSCIENCES INC+520,302+31.4%+$2.9M
NewAVALO THERAPEUTICS INC+150,000–+$2.8M
AddedPROMIS NEUROSCIENCES INC+206,100+49.8%+$2.7M
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outPRAXIS PRECISION MEDICINES I-32,810-100.0%$-10.6M
Sold outSOLENO THERAPEUTICS INC-200,000-100.0%$-6.7M
Sold outSOLENO THERAPEUTICS INCPUT-200,000-100.0%$-6.7M
ReducedOVID THERAPEUTICS INC-2,193,898-77.8%$-5.9M
Sold outCOMPASS PATHWAYS PLC-1,045,000-100.0%$-5.8M
Sold outTARSUS PHARMACEUTICALS INC-80,859-100.0%$-5.7M
Sold outCOMPASS THERAPEUTICS INCCALL-1,000,000-100.0%$-5.3M
ReducedSOLID BIOSCIENCES INC-511,015-66.6%$-5.1M
Sold outUNIQURE NVCALL-300,000-100.0%$-4.9M
ReducedUROGEN PHARMA LTD-132,941-65.8%$-4.9M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $583.5MQ1 2021: $521.6MQ2 2021: $402.5MQ3 2021: $340.1MQ4 2021: $286.1MQ1 2022: $134.9MQ2 2022: $109.7MQ3 2022: $151.5MQ4 2022: $102.8MQ1 2023: $76.3MQ2 2023: $82.6MQ3 2023: $85.2MQ4 2023: $167.8MQ1 2024: $179.9MQ2 2024: $167.9MQ3 2024: $186.8MQ4 2024: $116.6MQ1 2025: $110.9MQ2 2025: $120.2MQ3 2025: $164.2MQ4 2025: $96.0MQ1 2026: $123.8MQ2 2026: $113.1M
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1DEFINIUM THERAPEUTICS INCCALLCOM SHS400,000$18.8M16.64%
2ABIVAX SACALLSPONSORED ADS125,000$16.7M14.73%
3MINERVA NEUROSCIENCES INCCOM NEW2,175,802$12.1M10.68%
4PROMIS NEUROSCIENCES INCCOM SHS620,319$8.2M7.22%
5FIRST TRACKS BIOTHERAPEUTICSORD SHS284,287$5.7M5.06%
6AXSOME THERAPEUTICS INCCOM16,493$4.0M3.57%
7ASSEMBLY BIOSCIENCES INCCOM NEW140,000$3.8M3.40%
8WHITEHAWK THERAPEUTICS INCCOM817,939$3.7M3.31%
9EDGEWISE THERAPEUTICS INCCOM83,300$3.4M2.99%
10CLIMB BIO INCCOM249,172$3.2M2.87%
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.